Literature DB >> 32175420

Blockade of β-adrenergic signaling suppresses inflammasome and alleviates cardiac fibrosis.

Shipeng Dang1,2, Zhen-Ye Zhang2, Ku-Lin Li2, Jie Zheng2, Ling-Ling Qian2, Xiao-Yu Liu2, Ying Wu2, Chang-Ying Zhang2, Xiao-Xi Zhao2, Zhi-Ming Yu2, Ru-Xing Wang2, Tingbo Jiang1.   

Abstract

BACKGROUND: Heart failure (HF) is an end-stage syndrome of all structural heart diseases which accompanies the loss of myocardium and cardiac fibrosis. Although the role of inflammasome in cardiac fibrosis has recently been a point of focus, the mechanism of inflammasome activation in HF has not yet been elucidated.
METHODS: In this study, we investigated the expression of inflammasome proteins in a rat thoracic aorta constriction (TAC) model and cultured cardiac fibroblasts with stimulation of norepinephrine (NE).
RESULTS: Our results showed that levels of inflammasome proteins in the myocardial of TAC rats were elevated. By blocking β-adrenergic signaling in the rats, inflammasome activation was suppressed and heart function was improved. The stimulation of cultured cardiac fibroblasts with NE activated inflammasome in vitro, which was abrogated by the inhibition of the calcium channels and reactive oxygen species (ROS). The activation of inflammasome by NE promoted cardiac fibrosis, whereas the inhibition of the calcium channels, ROS, and inflammasome reduced this effect.
CONCLUSIONS: The present study indicated that activation of inflammasome by β-adrenergic signaling promotes cardiac fibrosis. Therefore, modulation of inflammasome during HF might provide a novel strategy to treat this disease. 2020 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Heart failure (HF); cardiac fibrosis; inflammasome; reactive oxygen species (ROS); β-adrenergic signaling

Year:  2020        PMID: 32175420      PMCID: PMC7048978          DOI: 10.21037/atm.2020.02.31

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  26 in total

Review 1.  Proinflammatory cytokines and ageing of the cardiovascular-renal system.

Authors:  Paweł Smykiewicz; Agnieszka Segiet; Michelle Keag; Tymoteusz Żera
Journal:  Mech Ageing Dev       Date:  2018-07-19       Impact factor: 5.432

2.  ASC Methylation and Interleukin-1β Are Associated with Aerobic Capacity in Heart Failure.

Authors:  Brittany Butts; Javed Butler; Sandra B Dunbar; Elizabeth J Corwin; Rebecca A Gary
Journal:  Med Sci Sports Exerc       Date:  2017-06       Impact factor: 5.411

3.  Heart failure: Clonal haematopoiesis, IL-1β, and the NLRP3 inflammasome in HF.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2018-03-13       Impact factor: 32.419

Review 4.  The inflammasome in myocardial injury and cardiac remodeling.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Adolfo Gabriele Mauro; Fadi Salloum; Benjamin Wallace Van Tassell; Antonio Abbate
Journal:  Antioxid Redox Signal       Date:  2014-12-11       Impact factor: 8.401

Review 5.  The Importance of NLRP3 Inflammasome in Heart Failure.

Authors:  Brittany Butts; Rebecca A Gary; Sandra B Dunbar; Javed Butler
Journal:  J Card Fail       Date:  2015-05-14       Impact factor: 5.712

6.  BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway.

Authors:  Wenbo Yang; Zhijun Wu; Ke Yang; Yanxin Han; Yanjia Chen; Weilin Zhao; Fanyi Huang; Yao Jin; Wei Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-25       Impact factor: 4.733

Review 7.  Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities.

Authors:  Ligia Akemi Kiyuna; Rudá Prestes E Albuquerque; Che-Hong Chen; Daria Mochly-Rosen; Julio Cesar Batista Ferreira
Journal:  Free Radic Biol Med       Date:  2018-09-15       Impact factor: 7.376

Review 8.  NLRP3: A Novel Mediator in Cardiovascular Disease.

Authors:  Wenyi Zhou; Chunyuan Chen; Zhiheng Chen; Lin Liu; Jie Jiang; Zhixiang Wu; Mingyi Zhao; Yanfang Chen
Journal:  J Immunol Res       Date:  2018-04-08       Impact factor: 4.818

9.  Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.

Authors:  Soichi Sano; Kosei Oshima; Ying Wang; Susan MacLauchlan; Yasufumi Katanasaka; Miho Sano; María A Zuriaga; Minoru Yoshiyama; David Goukassian; Matthew A Cooper; José J Fuster; Kenneth Walsh
Journal:  J Am Coll Cardiol       Date:  2018-02-27       Impact factor: 24.094

Review 10.  Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure.

Authors:  Nathan C Denham; Charles M Pearman; Jessica L Caldwell; George W P Madders; David A Eisner; Andrew W Trafford; Katharine M Dibb
Journal:  Front Physiol       Date:  2018-10-04       Impact factor: 4.566

View more
  6 in total

1.  The inflammasome in heart failure.

Authors:  Eleonora Mezzaroma; Antonio Abbate; Stefano Toldo
Journal:  Curr Opin Physiol       Date:  2020-10-07

2.  Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure.

Authors:  Yingdong Lu; Mi Xiang; Laiyun Xin; Yang Zhang; Yuling Wang; Zihuan Shen; Li Li; Xiangning Cui
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

3.  Glucose fluctuation promotes cardiomyocyte apoptosis by triggering endoplasmic reticulum (ER) stress signaling pathway in vivo and in vitro.

Authors:  Li-Da Wu; Ying Liu; Feng Li; Jia-Yi Chen; Jie Zhang; Ling-Ling Qian; Ru-Xing Wang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin.

Authors:  Henry Sutanto; Jordi Heijman
Journal:  Front Physiol       Date:  2020-10-22       Impact factor: 4.566

Review 5.  G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.

Authors:  Nan Li; Shan Shan; Xiu-Qin Li; Ting-Ting Chen; Meng Qi; Sheng-Nan Zhang; Zi-Ying Wang; Ling-Ling Zhang; Wei Wei; Wu-Yi Sun
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

6.  Cardiac Fibroblasts Mediate a Sexually Dimorphic Fibrotic Response to β-Adrenergic Stimulation.

Authors:  Angela K Peter; Cierra J Walker; Tova Ceccato; Christa L Trexler; Christopher D Ozeroff; Kimberly R Lugo; Amy R Perry; Kristi S Anseth; Leslie A Leinwand
Journal:  J Am Heart Assoc       Date:  2021-05-15       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.